390238 Sigma-AldrichCamptothecin, 10-Hydroxy-, Camptotheca acuminata - CAS 64439-81-2 - Calbiochem
A cell-permeable powerful DNA topoisomerase I inhibitor.
More>> A cell-permeable powerful DNA topoisomerase I inhibitor. Less<<Sinonimi: 10-Hydroxycamptothecin, HCPT
Prodotti consigliati
Panoramica
| Replacement Information |
|---|
Tabella delle specifiche principali
| CAS # | Empirical Formula |
|---|---|
| 64439-81-2 | C₂₀H₁₆N₂O₅ |
Prezzi e disponibilità
| Numero di catalogo | Disponibilità | Confezionamento | Qtà/conf | Prezzo | Quantità | |
|---|---|---|---|---|---|---|
| 390238-25MG |
|
Fiala di plastica | 25 mg |
|
— |
| References | |
|---|---|
| References | Zhang, X.W., et al. 1999. Anticancer Drugs. 10, 569. Ling, Y.H., et al. 1993. Anticancer Res. 13, 1613. Wani, M.C., and Wall, M.E. 1969. J. Org. Chem. 34, 1364. |
| Product Information | |
|---|---|
| CAS number | 64439-81-2 |
| ATP Competitive | N |
| Form | Pale yellow powder |
| Hill Formula | C₂₀H₁₆N₂O₅ |
| Chemical formula | C₂₀H₁₆N₂O₅ |
| Reversible | N |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications |
|---|
| Biological Information | |
|---|---|
| Primary Target | DNA topoisomerase I |
| Purity | ≥95% by HPLC |
| Physicochemical Information | |
|---|---|
| Cell permeable | Y |
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Numero di catalogo | GTIN |
| 390238-25MG | 04055977189988 |
Documentation
Camptothecin, 10-Hydroxy-, Camptotheca acuminata - CAS 64439-81-2 - Calbiochem MSDS
| Titolo |
|---|
Camptothecin, 10-Hydroxy-, Camptotheca acuminata - CAS 64439-81-2 - Calbiochem Certificati d'Analisi
| Titolo | Numero di lotto |
|---|---|
| 390238 |
Riferimenti bibliografici
| Panoramica delle referenze |
|---|
| Zhang, X.W., et al. 1999. Anticancer Drugs. 10, 569. Ling, Y.H., et al. 1993. Anticancer Res. 13, 1613. Wani, M.C., and Wall, M.E. 1969. J. Org. Chem. 34, 1364. |



